Role of PHGDH-mediated metabolic reprogramming in oxaliplatin resistance of gastric cancer cells and its prognostic value

WANG Li; FENG Qianqian; LIU Hui; WEI Lin; SHI Hailong

doi:10.12289/j.issn.2097-4345.25036

Journal of Tongji University(Medical Science), Volume. 46, Issue 3, 319(2025)

Role of PHGDH-mediated metabolic reprogramming in oxaliplatin resistance of gastric cancer cells and its prognostic value

WANG Li¹, FENG Qianqian², LIU Hui³, WEI Lin³, and SHI Hailong^3、*

Author Affiliations

¹Department 1 of Mediastinal Lung Tumor Internal Medicine, Tai'an City Central Hospital, Tai'an 271000, Shandong Province, China

²Department 2 of Mediastinal Lung Tumor Internal Medicine, Tai'an City Central Hospital, Tai'an 271000, Shandong Province, China

³Department of Tumor Rehabilitation, Tai'an City Central Hospital, Tai'an 271000, Shandong Province, China

show less

Abstract Get PDF(in Chinese)

Figures & Tables(0)

Tools

Get Citation

Copy Citation Text

WANG Li, FENG Qianqian, LIU Hui, WEI Lin, SHI Hailong. Role of PHGDH-mediated metabolic reprogramming in oxaliplatin resistance of gastric cancer cells and its prognostic value[J]. Journal of Tongji University(Medical Science), 2025, 46(3): 319

Download Citation

EndNote(RIS)BibTex Plain Text

Set citation alerts for article

Save article for my favorites

Paper Information

Category:

Received: Jan. 31, 2025

Accepted: Aug. 26, 2025

Published Online: Aug. 26, 2025

The Author Email: SHI Hailong (shl880723@126.com)

DOI:10.12289/j.issn.2097-4345.25036

Topics